These include “aspirin reduction in cancer-associated inflammation, abnormal clotting and abnormal blood vessel growth, and increased cell repair”.
Researchers say several studies show that aspirin can increase the chances of survival in various types of cancer by about 20 percent. Some studies have also shown that the spread of cancer is reduced by about a third.
However, he emphasized the importance of further evidence because different trials gave different results. They state that “there appears to be an impressive concordance between the biological effects of aspirin on cancer-related mechanisms and the effects of aspirin on clinical outcomes in cancer”.
Based on the results, they considered aspirin a “relatively safe drug”, particularly among cancer patients.
Sam Godfrey, Head of Research Information at Cancer Research UK, told Times UK: “This review examines what we know so far about the interesting effects of aspirin on cancer biology and how it improves survival. and may help prevent cancer from spreading to other areas of the body. Other parts of the body. But we still need more clinical research to determine how effective aspirin is in patients. What are the benefits of taking the drug and how much should they take and for how long?
Read also: Not hugged or carried, this is the most powerful kick to relieve a baby’s cry
“To help answer some of these questions, Cancer Research UK is funding ad-aspirin, the world’s largest clinical trial, which is studying whether aspirin can return certain types of cancer. can stop it or not.”
Around 11,000 patients from the UK, Ireland and India are expected to participate in the new trial. These patients will undergo early-stage cancer treatment to see if regular aspirin use can prevent recurrence or death. ,